SEC Form 4/A · accession 0001628280-18-003730
NEOGENOMICS INC · NEO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Douglas M Van Oort
Officer — Chairman and CEO
Period of report
Feb 26, 2018
Accepted (ET)
Mar 28, 2018 · 4:58 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001077183
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1,F2 | $8.03 | Feb 26, 2018 | A | 500,000 | A | Feb 26, 2019 | Feb 26, 2023 | Common Stock | 500,000 | 500,000 | D |
Explanation of responses
- F1The number of shares of common stock covered by this stock option grant exceeded a limitation applicable to equity awards under the Amended and Restated Equity Incentive Plan and 136,000 excess options were rescinded. This Amended Form 4 reflects the corrected number of stock options granted. Except as otherwise stated above, the vesting and other terms and conditions of the stock option will remain unchanged.
- F2On February 26, 2018, Mr. VanOort was granted stock options; these stock options vest ratably over the first three anniversary dates of the grant date.